Philip Ward and Rebekah Moan[email protected]ConferenceControversy persists over breast screening for under 50sVIENNA - Screening is effective in reducing breast cancer mortality in women ages 40 to 49, but false positives remain a serious problem, European Congress of Radiology attendees were told at a special focus session on Friday.March 2, 2012Page 1 of 1Top StoriesMolecular ImagingF-18 PSMA PET-CT proves clinical value in prostate cancerF-18 prostate-specific membrane antigen (PSMA) PET/CT is having a major impact on patient care and therapy decisions in prostate cancer, but it’s crucial to bear in mind the modality’s diagnostic quirks.Molecular ImagingCombined PET scans predict progression of Alzheimer’sMolecular ImagingPET scans predict outcomes for patients undergoing CAR T-cell therapyMRIMRI-based nomogram provides boost in breast cancerCTCT estimated to cause 5% of new cancer cases